Global Kidney Fibrosis Drugs Supply, Demand and Key Producers, 2023-2029
The global Kidney Fibrosis Drugs market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global Kidney Fibrosis Drugs production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Kidney Fibrosis Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Kidney Fibrosis Drugs that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Kidney Fibrosis Drugs total production and demand, 2018-2029, (K Units)
Global Kidney Fibrosis Drugs total production value, 2018-2029, (USD Million)
Global Kidney Fibrosis Drugs production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Kidney Fibrosis Drugs consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Kidney Fibrosis Drugs domestic production, consumption, key domestic manufacturers and share
Global Kidney Fibrosis Drugs production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Kidney Fibrosis Drugs production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Kidney Fibrosis Drugs production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Kidney Fibrosis Drugs market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck and Co, Galectin Therapeutics, Pfizer Inc, InterMune Inc, La Jolla Pharmaceutical Company, BioLine Rx, F. Hoffman-La Roche, ProMetic Life-Sciences Inc and Genzyme Corporation, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Kidney Fibrosis Drugs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Kidney Fibrosis Drugs Market, By Region:
1. How big is the global Kidney Fibrosis Drugs market?
2. What is the demand of the global Kidney Fibrosis Drugs market?
3. What is the year over year growth of the global Kidney Fibrosis Drugs market?
4. What is the production and production value of the global Kidney Fibrosis Drugs market?
5. Who are the key producers in the global Kidney Fibrosis Drugs market?
6. What are the growth factors driving the market demand?
This report studies the global Kidney Fibrosis Drugs production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Kidney Fibrosis Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Kidney Fibrosis Drugs that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Kidney Fibrosis Drugs total production and demand, 2018-2029, (K Units)
Global Kidney Fibrosis Drugs total production value, 2018-2029, (USD Million)
Global Kidney Fibrosis Drugs production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Kidney Fibrosis Drugs consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Kidney Fibrosis Drugs domestic production, consumption, key domestic manufacturers and share
Global Kidney Fibrosis Drugs production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Kidney Fibrosis Drugs production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Kidney Fibrosis Drugs production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Kidney Fibrosis Drugs market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck and Co, Galectin Therapeutics, Pfizer Inc, InterMune Inc, La Jolla Pharmaceutical Company, BioLine Rx, F. Hoffman-La Roche, ProMetic Life-Sciences Inc and Genzyme Corporation, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Kidney Fibrosis Drugs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Kidney Fibrosis Drugs Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Angiotensin Converting Enzyme (ACE) Inhibitors
- Pirfenidone
- Renin Inhibitors
- Angiotensin II Receptor Blockers (ARBs)
- Vasopeptidase Inhibitors
- Chronic Kidney Diseases
- Kidney Cancer Treatment
- Others
- Merck and Co
- Galectin Therapeutics
- Pfizer Inc
- InterMune Inc
- La Jolla Pharmaceutical Company
- BioLine Rx
- F. Hoffman-La Roche
- ProMetic Life-Sciences Inc
- Genzyme Corporation
1. How big is the global Kidney Fibrosis Drugs market?
2. What is the demand of the global Kidney Fibrosis Drugs market?
3. What is the year over year growth of the global Kidney Fibrosis Drugs market?
4. What is the production and production value of the global Kidney Fibrosis Drugs market?
5. Who are the key producers in the global Kidney Fibrosis Drugs market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Kidney Fibrosis Drugs Introduction
1.2 World Kidney Fibrosis Drugs Supply & Forecast
1.2.1 World Kidney Fibrosis Drugs Production Value (2018 & 2022 & 2029)
1.2.2 World Kidney Fibrosis Drugs Production (2018-2029)
1.2.3 World Kidney Fibrosis Drugs Pricing Trends (2018-2029)
1.3 World Kidney Fibrosis Drugs Production by Region (Based on Production Site)
1.3.1 World Kidney Fibrosis Drugs Production Value by Region (2018-2029)
1.3.2 World Kidney Fibrosis Drugs Production by Region (2018-2029)
1.3.3 World Kidney Fibrosis Drugs Average Price by Region (2018-2029)
1.3.4 North America Kidney Fibrosis Drugs Production (2018-2029)
1.3.5 Europe Kidney Fibrosis Drugs Production (2018-2029)
1.3.6 China Kidney Fibrosis Drugs Production (2018-2029)
1.3.7 Japan Kidney Fibrosis Drugs Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Kidney Fibrosis Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Kidney Fibrosis Drugs Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Kidney Fibrosis Drugs Demand (2018-2029)
2.2 World Kidney Fibrosis Drugs Consumption by Region
2.2.1 World Kidney Fibrosis Drugs Consumption by Region (2018-2023)
2.2.2 World Kidney Fibrosis Drugs Consumption Forecast by Region (2024-2029)
2.3 United States Kidney Fibrosis Drugs Consumption (2018-2029)
2.4 China Kidney Fibrosis Drugs Consumption (2018-2029)
2.5 Europe Kidney Fibrosis Drugs Consumption (2018-2029)
2.6 Japan Kidney Fibrosis Drugs Consumption (2018-2029)
2.7 South Korea Kidney Fibrosis Drugs Consumption (2018-2029)
2.8 ASEAN Kidney Fibrosis Drugs Consumption (2018-2029)
2.9 India Kidney Fibrosis Drugs Consumption (2018-2029)
3 WORLD KIDNEY FIBROSIS DRUGS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Kidney Fibrosis Drugs Production Value by Manufacturer (2018-2023)
3.2 World Kidney Fibrosis Drugs Production by Manufacturer (2018-2023)
3.3 World Kidney Fibrosis Drugs Average Price by Manufacturer (2018-2023)
3.4 Kidney Fibrosis Drugs Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Kidney Fibrosis Drugs Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Kidney Fibrosis Drugs in 2022
3.5.3 Global Concentration Ratios (CR8) for Kidney Fibrosis Drugs in 2022
3.6 Kidney Fibrosis Drugs Market: Overall Company Footprint Analysis
3.6.1 Kidney Fibrosis Drugs Market: Region Footprint
3.6.2 Kidney Fibrosis Drugs Market: Company Product Type Footprint
3.6.3 Kidney Fibrosis Drugs Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Kidney Fibrosis Drugs Production Value Comparison
4.1.1 United States VS China: Kidney Fibrosis Drugs Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Kidney Fibrosis Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Kidney Fibrosis Drugs Production Comparison
4.2.1 United States VS China: Kidney Fibrosis Drugs Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Kidney Fibrosis Drugs Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Kidney Fibrosis Drugs Consumption Comparison
4.3.1 United States VS China: Kidney Fibrosis Drugs Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Kidney Fibrosis Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Kidney Fibrosis Drugs Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Kidney Fibrosis Drugs Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Kidney Fibrosis Drugs Production Value (2018-2023)
4.4.3 United States Based Manufacturers Kidney Fibrosis Drugs Production (2018-2023)
4.5 China Based Kidney Fibrosis Drugs Manufacturers and Market Share
4.5.1 China Based Kidney Fibrosis Drugs Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Kidney Fibrosis Drugs Production Value (2018-2023)
4.5.3 China Based Manufacturers Kidney Fibrosis Drugs Production (2018-2023)
4.6 Rest of World Based Kidney Fibrosis Drugs Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Kidney Fibrosis Drugs Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Kidney Fibrosis Drugs Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Kidney Fibrosis Drugs Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Kidney Fibrosis Drugs Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Angiotensin Converting Enzyme (ACE) Inhibitors
5.2.2 Pirfenidone
5.2.3 Renin Inhibitors
5.2.4 Angiotensin II Receptor Blockers (ARBs)
5.2.5 Vasopeptidase Inhibitors
5.3 Market Segment by Type
5.3.1 World Kidney Fibrosis Drugs Production by Type (2018-2029)
5.3.2 World Kidney Fibrosis Drugs Production Value by Type (2018-2029)
5.3.3 World Kidney Fibrosis Drugs Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Kidney Fibrosis Drugs Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Chronic Kidney Diseases
6.2.2 Kidney Cancer Treatment
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Kidney Fibrosis Drugs Production by Application (2018-2029)
6.3.2 World Kidney Fibrosis Drugs Production Value by Application (2018-2029)
6.3.3 World Kidney Fibrosis Drugs Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Merck and Co
7.1.1 Merck and Co Details
7.1.2 Merck and Co Major Business
7.1.3 Merck and Co Kidney Fibrosis Drugs Product and Services
7.1.4 Merck and Co Kidney Fibrosis Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Merck and Co Recent Developments/Updates
7.1.6 Merck and Co Competitive Strengths & Weaknesses
7.2 Galectin Therapeutics
7.2.1 Galectin Therapeutics Details
7.2.2 Galectin Therapeutics Major Business
7.2.3 Galectin Therapeutics Kidney Fibrosis Drugs Product and Services
7.2.4 Galectin Therapeutics Kidney Fibrosis Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Galectin Therapeutics Recent Developments/Updates
7.2.6 Galectin Therapeutics Competitive Strengths & Weaknesses
7.3 Pfizer Inc
7.3.1 Pfizer Inc Details
7.3.2 Pfizer Inc Major Business
7.3.3 Pfizer Inc Kidney Fibrosis Drugs Product and Services
7.3.4 Pfizer Inc Kidney Fibrosis Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Pfizer Inc Recent Developments/Updates
7.3.6 Pfizer Inc Competitive Strengths & Weaknesses
7.4 InterMune Inc
7.4.1 InterMune Inc Details
7.4.2 InterMune Inc Major Business
7.4.3 InterMune Inc Kidney Fibrosis Drugs Product and Services
7.4.4 InterMune Inc Kidney Fibrosis Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 InterMune Inc Recent Developments/Updates
7.4.6 InterMune Inc Competitive Strengths & Weaknesses
7.5 La Jolla Pharmaceutical Company
7.5.1 La Jolla Pharmaceutical Company Details
7.5.2 La Jolla Pharmaceutical Company Major Business
7.5.3 La Jolla Pharmaceutical Company Kidney Fibrosis Drugs Product and Services
7.5.4 La Jolla Pharmaceutical Company Kidney Fibrosis Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 La Jolla Pharmaceutical Company Recent Developments/Updates
7.5.6 La Jolla Pharmaceutical Company Competitive Strengths & Weaknesses
7.6 BioLine Rx
7.6.1 BioLine Rx Details
7.6.2 BioLine Rx Major Business
7.6.3 BioLine Rx Kidney Fibrosis Drugs Product and Services
7.6.4 BioLine Rx Kidney Fibrosis Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 BioLine Rx Recent Developments/Updates
7.6.6 BioLine Rx Competitive Strengths & Weaknesses
7.7 F. Hoffman-La Roche
7.7.1 F. Hoffman-La Roche Details
7.7.2 F. Hoffman-La Roche Major Business
7.7.3 F. Hoffman-La Roche Kidney Fibrosis Drugs Product and Services
7.7.4 F. Hoffman-La Roche Kidney Fibrosis Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 F. Hoffman-La Roche Recent Developments/Updates
7.7.6 F. Hoffman-La Roche Competitive Strengths & Weaknesses
7.8 ProMetic Life-Sciences Inc
7.8.1 ProMetic Life-Sciences Inc Details
7.8.2 ProMetic Life-Sciences Inc Major Business
7.8.3 ProMetic Life-Sciences Inc Kidney Fibrosis Drugs Product and Services
7.8.4 ProMetic Life-Sciences Inc Kidney Fibrosis Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 ProMetic Life-Sciences Inc Recent Developments/Updates
7.8.6 ProMetic Life-Sciences Inc Competitive Strengths & Weaknesses
7.9 Genzyme Corporation
7.9.1 Genzyme Corporation Details
7.9.2 Genzyme Corporation Major Business
7.9.3 Genzyme Corporation Kidney Fibrosis Drugs Product and Services
7.9.4 Genzyme Corporation Kidney Fibrosis Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Genzyme Corporation Recent Developments/Updates
7.9.6 Genzyme Corporation Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Kidney Fibrosis Drugs Industry Chain
8.2 Kidney Fibrosis Drugs Upstream Analysis
8.2.1 Kidney Fibrosis Drugs Core Raw Materials
8.2.2 Main Manufacturers of Kidney Fibrosis Drugs Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Kidney Fibrosis Drugs Production Mode
8.6 Kidney Fibrosis Drugs Procurement Model
8.7 Kidney Fibrosis Drugs Industry Sales Model and Sales Channels
8.7.1 Kidney Fibrosis Drugs Sales Model
8.7.2 Kidney Fibrosis Drugs Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Kidney Fibrosis Drugs Introduction
1.2 World Kidney Fibrosis Drugs Supply & Forecast
1.2.1 World Kidney Fibrosis Drugs Production Value (2018 & 2022 & 2029)
1.2.2 World Kidney Fibrosis Drugs Production (2018-2029)
1.2.3 World Kidney Fibrosis Drugs Pricing Trends (2018-2029)
1.3 World Kidney Fibrosis Drugs Production by Region (Based on Production Site)
1.3.1 World Kidney Fibrosis Drugs Production Value by Region (2018-2029)
1.3.2 World Kidney Fibrosis Drugs Production by Region (2018-2029)
1.3.3 World Kidney Fibrosis Drugs Average Price by Region (2018-2029)
1.3.4 North America Kidney Fibrosis Drugs Production (2018-2029)
1.3.5 Europe Kidney Fibrosis Drugs Production (2018-2029)
1.3.6 China Kidney Fibrosis Drugs Production (2018-2029)
1.3.7 Japan Kidney Fibrosis Drugs Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Kidney Fibrosis Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Kidney Fibrosis Drugs Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Kidney Fibrosis Drugs Demand (2018-2029)
2.2 World Kidney Fibrosis Drugs Consumption by Region
2.2.1 World Kidney Fibrosis Drugs Consumption by Region (2018-2023)
2.2.2 World Kidney Fibrosis Drugs Consumption Forecast by Region (2024-2029)
2.3 United States Kidney Fibrosis Drugs Consumption (2018-2029)
2.4 China Kidney Fibrosis Drugs Consumption (2018-2029)
2.5 Europe Kidney Fibrosis Drugs Consumption (2018-2029)
2.6 Japan Kidney Fibrosis Drugs Consumption (2018-2029)
2.7 South Korea Kidney Fibrosis Drugs Consumption (2018-2029)
2.8 ASEAN Kidney Fibrosis Drugs Consumption (2018-2029)
2.9 India Kidney Fibrosis Drugs Consumption (2018-2029)
3 WORLD KIDNEY FIBROSIS DRUGS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Kidney Fibrosis Drugs Production Value by Manufacturer (2018-2023)
3.2 World Kidney Fibrosis Drugs Production by Manufacturer (2018-2023)
3.3 World Kidney Fibrosis Drugs Average Price by Manufacturer (2018-2023)
3.4 Kidney Fibrosis Drugs Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Kidney Fibrosis Drugs Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Kidney Fibrosis Drugs in 2022
3.5.3 Global Concentration Ratios (CR8) for Kidney Fibrosis Drugs in 2022
3.6 Kidney Fibrosis Drugs Market: Overall Company Footprint Analysis
3.6.1 Kidney Fibrosis Drugs Market: Region Footprint
3.6.2 Kidney Fibrosis Drugs Market: Company Product Type Footprint
3.6.3 Kidney Fibrosis Drugs Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Kidney Fibrosis Drugs Production Value Comparison
4.1.1 United States VS China: Kidney Fibrosis Drugs Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Kidney Fibrosis Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Kidney Fibrosis Drugs Production Comparison
4.2.1 United States VS China: Kidney Fibrosis Drugs Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Kidney Fibrosis Drugs Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Kidney Fibrosis Drugs Consumption Comparison
4.3.1 United States VS China: Kidney Fibrosis Drugs Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Kidney Fibrosis Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Kidney Fibrosis Drugs Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Kidney Fibrosis Drugs Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Kidney Fibrosis Drugs Production Value (2018-2023)
4.4.3 United States Based Manufacturers Kidney Fibrosis Drugs Production (2018-2023)
4.5 China Based Kidney Fibrosis Drugs Manufacturers and Market Share
4.5.1 China Based Kidney Fibrosis Drugs Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Kidney Fibrosis Drugs Production Value (2018-2023)
4.5.3 China Based Manufacturers Kidney Fibrosis Drugs Production (2018-2023)
4.6 Rest of World Based Kidney Fibrosis Drugs Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Kidney Fibrosis Drugs Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Kidney Fibrosis Drugs Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Kidney Fibrosis Drugs Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Kidney Fibrosis Drugs Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Angiotensin Converting Enzyme (ACE) Inhibitors
5.2.2 Pirfenidone
5.2.3 Renin Inhibitors
5.2.4 Angiotensin II Receptor Blockers (ARBs)
5.2.5 Vasopeptidase Inhibitors
5.3 Market Segment by Type
5.3.1 World Kidney Fibrosis Drugs Production by Type (2018-2029)
5.3.2 World Kidney Fibrosis Drugs Production Value by Type (2018-2029)
5.3.3 World Kidney Fibrosis Drugs Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Kidney Fibrosis Drugs Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Chronic Kidney Diseases
6.2.2 Kidney Cancer Treatment
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Kidney Fibrosis Drugs Production by Application (2018-2029)
6.3.2 World Kidney Fibrosis Drugs Production Value by Application (2018-2029)
6.3.3 World Kidney Fibrosis Drugs Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Merck and Co
7.1.1 Merck and Co Details
7.1.2 Merck and Co Major Business
7.1.3 Merck and Co Kidney Fibrosis Drugs Product and Services
7.1.4 Merck and Co Kidney Fibrosis Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Merck and Co Recent Developments/Updates
7.1.6 Merck and Co Competitive Strengths & Weaknesses
7.2 Galectin Therapeutics
7.2.1 Galectin Therapeutics Details
7.2.2 Galectin Therapeutics Major Business
7.2.3 Galectin Therapeutics Kidney Fibrosis Drugs Product and Services
7.2.4 Galectin Therapeutics Kidney Fibrosis Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Galectin Therapeutics Recent Developments/Updates
7.2.6 Galectin Therapeutics Competitive Strengths & Weaknesses
7.3 Pfizer Inc
7.3.1 Pfizer Inc Details
7.3.2 Pfizer Inc Major Business
7.3.3 Pfizer Inc Kidney Fibrosis Drugs Product and Services
7.3.4 Pfizer Inc Kidney Fibrosis Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Pfizer Inc Recent Developments/Updates
7.3.6 Pfizer Inc Competitive Strengths & Weaknesses
7.4 InterMune Inc
7.4.1 InterMune Inc Details
7.4.2 InterMune Inc Major Business
7.4.3 InterMune Inc Kidney Fibrosis Drugs Product and Services
7.4.4 InterMune Inc Kidney Fibrosis Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 InterMune Inc Recent Developments/Updates
7.4.6 InterMune Inc Competitive Strengths & Weaknesses
7.5 La Jolla Pharmaceutical Company
7.5.1 La Jolla Pharmaceutical Company Details
7.5.2 La Jolla Pharmaceutical Company Major Business
7.5.3 La Jolla Pharmaceutical Company Kidney Fibrosis Drugs Product and Services
7.5.4 La Jolla Pharmaceutical Company Kidney Fibrosis Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 La Jolla Pharmaceutical Company Recent Developments/Updates
7.5.6 La Jolla Pharmaceutical Company Competitive Strengths & Weaknesses
7.6 BioLine Rx
7.6.1 BioLine Rx Details
7.6.2 BioLine Rx Major Business
7.6.3 BioLine Rx Kidney Fibrosis Drugs Product and Services
7.6.4 BioLine Rx Kidney Fibrosis Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 BioLine Rx Recent Developments/Updates
7.6.6 BioLine Rx Competitive Strengths & Weaknesses
7.7 F. Hoffman-La Roche
7.7.1 F. Hoffman-La Roche Details
7.7.2 F. Hoffman-La Roche Major Business
7.7.3 F. Hoffman-La Roche Kidney Fibrosis Drugs Product and Services
7.7.4 F. Hoffman-La Roche Kidney Fibrosis Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 F. Hoffman-La Roche Recent Developments/Updates
7.7.6 F. Hoffman-La Roche Competitive Strengths & Weaknesses
7.8 ProMetic Life-Sciences Inc
7.8.1 ProMetic Life-Sciences Inc Details
7.8.2 ProMetic Life-Sciences Inc Major Business
7.8.3 ProMetic Life-Sciences Inc Kidney Fibrosis Drugs Product and Services
7.8.4 ProMetic Life-Sciences Inc Kidney Fibrosis Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 ProMetic Life-Sciences Inc Recent Developments/Updates
7.8.6 ProMetic Life-Sciences Inc Competitive Strengths & Weaknesses
7.9 Genzyme Corporation
7.9.1 Genzyme Corporation Details
7.9.2 Genzyme Corporation Major Business
7.9.3 Genzyme Corporation Kidney Fibrosis Drugs Product and Services
7.9.4 Genzyme Corporation Kidney Fibrosis Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Genzyme Corporation Recent Developments/Updates
7.9.6 Genzyme Corporation Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Kidney Fibrosis Drugs Industry Chain
8.2 Kidney Fibrosis Drugs Upstream Analysis
8.2.1 Kidney Fibrosis Drugs Core Raw Materials
8.2.2 Main Manufacturers of Kidney Fibrosis Drugs Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Kidney Fibrosis Drugs Production Mode
8.6 Kidney Fibrosis Drugs Procurement Model
8.7 Kidney Fibrosis Drugs Industry Sales Model and Sales Channels
8.7.1 Kidney Fibrosis Drugs Sales Model
8.7.2 Kidney Fibrosis Drugs Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Kidney Fibrosis Drugs Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Kidney Fibrosis Drugs Production Value by Region (2018-2023) & (USD Million)
Table 3. World Kidney Fibrosis Drugs Production Value by Region (2024-2029) & (USD Million)
Table 4. World Kidney Fibrosis Drugs Production Value Market Share by Region (2018-2023)
Table 5. World Kidney Fibrosis Drugs Production Value Market Share by Region (2024-2029)
Table 6. World Kidney Fibrosis Drugs Production by Region (2018-2023) & (K Units)
Table 7. World Kidney Fibrosis Drugs Production by Region (2024-2029) & (K Units)
Table 8. World Kidney Fibrosis Drugs Production Market Share by Region (2018-2023)
Table 9. World Kidney Fibrosis Drugs Production Market Share by Region (2024-2029)
Table 10. World Kidney Fibrosis Drugs Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Kidney Fibrosis Drugs Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Kidney Fibrosis Drugs Major Market Trends
Table 13. World Kidney Fibrosis Drugs Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Kidney Fibrosis Drugs Consumption by Region (2018-2023) & (K Units)
Table 15. World Kidney Fibrosis Drugs Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Kidney Fibrosis Drugs Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Kidney Fibrosis Drugs Producers in 2022
Table 18. World Kidney Fibrosis Drugs Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Kidney Fibrosis Drugs Producers in 2022
Table 20. World Kidney Fibrosis Drugs Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Kidney Fibrosis Drugs Company Evaluation Quadrant
Table 22. World Kidney Fibrosis Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Kidney Fibrosis Drugs Production Site of Key Manufacturer
Table 24. Kidney Fibrosis Drugs Market: Company Product Type Footprint
Table 25. Kidney Fibrosis Drugs Market: Company Product Application Footprint
Table 26. Kidney Fibrosis Drugs Competitive Factors
Table 27. Kidney Fibrosis Drugs New Entrant and Capacity Expansion Plans
Table 28. Kidney Fibrosis Drugs Mergers & Acquisitions Activity
Table 29. United States VS China Kidney Fibrosis Drugs Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Kidney Fibrosis Drugs Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Kidney Fibrosis Drugs Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Kidney Fibrosis Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Kidney Fibrosis Drugs Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Kidney Fibrosis Drugs Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Kidney Fibrosis Drugs Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Kidney Fibrosis Drugs Production Market Share (2018-2023)
Table 37. China Based Kidney Fibrosis Drugs Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Kidney Fibrosis Drugs Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Kidney Fibrosis Drugs Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Kidney Fibrosis Drugs Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Kidney Fibrosis Drugs Production Market Share (2018-2023)
Table 42. Rest of World Based Kidney Fibrosis Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Kidney Fibrosis Drugs Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Kidney Fibrosis Drugs Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Kidney Fibrosis Drugs Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Kidney Fibrosis Drugs Production Market Share (2018-2023)
Table 47. World Kidney Fibrosis Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Kidney Fibrosis Drugs Production by Type (2018-2023) & (K Units)
Table 49. World Kidney Fibrosis Drugs Production by Type (2024-2029) & (K Units)
Table 50. World Kidney Fibrosis Drugs Production Value by Type (2018-2023) & (USD Million)
Table 51. World Kidney Fibrosis Drugs Production Value by Type (2024-2029) & (USD Million)
Table 52. World Kidney Fibrosis Drugs Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Kidney Fibrosis Drugs Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Kidney Fibrosis Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Kidney Fibrosis Drugs Production by Application (2018-2023) & (K Units)
Table 56. World Kidney Fibrosis Drugs Production by Application (2024-2029) & (K Units)
Table 57. World Kidney Fibrosis Drugs Production Value by Application (2018-2023) & (USD Million)
Table 58. World Kidney Fibrosis Drugs Production Value by Application (2024-2029) & (USD Million)
Table 59. World Kidney Fibrosis Drugs Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Kidney Fibrosis Drugs Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Merck and Co Basic Information, Manufacturing Base and Competitors
Table 62. Merck and Co Major Business
Table 63. Merck and Co Kidney Fibrosis Drugs Product and Services
Table 64. Merck and Co Kidney Fibrosis Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Merck and Co Recent Developments/Updates
Table 66. Merck and Co Competitive Strengths & Weaknesses
Table 67. Galectin Therapeutics Basic Information, Manufacturing Base and Competitors
Table 68. Galectin Therapeutics Major Business
Table 69. Galectin Therapeutics Kidney Fibrosis Drugs Product and Services
Table 70. Galectin Therapeutics Kidney Fibrosis Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Galectin Therapeutics Recent Developments/Updates
Table 72. Galectin Therapeutics Competitive Strengths & Weaknesses
Table 73. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 74. Pfizer Inc Major Business
Table 75. Pfizer Inc Kidney Fibrosis Drugs Product and Services
Table 76. Pfizer Inc Kidney Fibrosis Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Pfizer Inc Recent Developments/Updates
Table 78. Pfizer Inc Competitive Strengths & Weaknesses
Table 79. InterMune Inc Basic Information, Manufacturing Base and Competitors
Table 80. InterMune Inc Major Business
Table 81. InterMune Inc Kidney Fibrosis Drugs Product and Services
Table 82. InterMune Inc Kidney Fibrosis Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. InterMune Inc Recent Developments/Updates
Table 84. InterMune Inc Competitive Strengths & Weaknesses
Table 85. La Jolla Pharmaceutical Company Basic Information, Manufacturing Base and Competitors
Table 86. La Jolla Pharmaceutical Company Major Business
Table 87. La Jolla Pharmaceutical Company Kidney Fibrosis Drugs Product and Services
Table 88. La Jolla Pharmaceutical Company Kidney Fibrosis Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. La Jolla Pharmaceutical Company Recent Developments/Updates
Table 90. La Jolla Pharmaceutical Company Competitive Strengths & Weaknesses
Table 91. BioLine Rx Basic Information, Manufacturing Base and Competitors
Table 92. BioLine Rx Major Business
Table 93. BioLine Rx Kidney Fibrosis Drugs Product and Services
Table 94. BioLine Rx Kidney Fibrosis Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. BioLine Rx Recent Developments/Updates
Table 96. BioLine Rx Competitive Strengths & Weaknesses
Table 97. F. Hoffman-La Roche Basic Information, Manufacturing Base and Competitors
Table 98. F. Hoffman-La Roche Major Business
Table 99. F. Hoffman-La Roche Kidney Fibrosis Drugs Product and Services
Table 100. F. Hoffman-La Roche Kidney Fibrosis Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. F. Hoffman-La Roche Recent Developments/Updates
Table 102. F. Hoffman-La Roche Competitive Strengths & Weaknesses
Table 103. ProMetic Life-Sciences Inc Basic Information, Manufacturing Base and Competitors
Table 104. ProMetic Life-Sciences Inc Major Business
Table 105. ProMetic Life-Sciences Inc Kidney Fibrosis Drugs Product and Services
Table 106. ProMetic Life-Sciences Inc Kidney Fibrosis Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. ProMetic Life-Sciences Inc Recent Developments/Updates
Table 108. Genzyme Corporation Basic Information, Manufacturing Base and Competitors
Table 109. Genzyme Corporation Major Business
Table 110. Genzyme Corporation Kidney Fibrosis Drugs Product and Services
Table 111. Genzyme Corporation Kidney Fibrosis Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 112. Global Key Players of Kidney Fibrosis Drugs Upstream (Raw Materials)
Table 113. Kidney Fibrosis Drugs Typical Customers
Table 114. Kidney Fibrosis Drugs Typical Distributors
Table 1. World Kidney Fibrosis Drugs Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Kidney Fibrosis Drugs Production Value by Region (2018-2023) & (USD Million)
Table 3. World Kidney Fibrosis Drugs Production Value by Region (2024-2029) & (USD Million)
Table 4. World Kidney Fibrosis Drugs Production Value Market Share by Region (2018-2023)
Table 5. World Kidney Fibrosis Drugs Production Value Market Share by Region (2024-2029)
Table 6. World Kidney Fibrosis Drugs Production by Region (2018-2023) & (K Units)
Table 7. World Kidney Fibrosis Drugs Production by Region (2024-2029) & (K Units)
Table 8. World Kidney Fibrosis Drugs Production Market Share by Region (2018-2023)
Table 9. World Kidney Fibrosis Drugs Production Market Share by Region (2024-2029)
Table 10. World Kidney Fibrosis Drugs Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Kidney Fibrosis Drugs Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Kidney Fibrosis Drugs Major Market Trends
Table 13. World Kidney Fibrosis Drugs Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Kidney Fibrosis Drugs Consumption by Region (2018-2023) & (K Units)
Table 15. World Kidney Fibrosis Drugs Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Kidney Fibrosis Drugs Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Kidney Fibrosis Drugs Producers in 2022
Table 18. World Kidney Fibrosis Drugs Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Kidney Fibrosis Drugs Producers in 2022
Table 20. World Kidney Fibrosis Drugs Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Kidney Fibrosis Drugs Company Evaluation Quadrant
Table 22. World Kidney Fibrosis Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Kidney Fibrosis Drugs Production Site of Key Manufacturer
Table 24. Kidney Fibrosis Drugs Market: Company Product Type Footprint
Table 25. Kidney Fibrosis Drugs Market: Company Product Application Footprint
Table 26. Kidney Fibrosis Drugs Competitive Factors
Table 27. Kidney Fibrosis Drugs New Entrant and Capacity Expansion Plans
Table 28. Kidney Fibrosis Drugs Mergers & Acquisitions Activity
Table 29. United States VS China Kidney Fibrosis Drugs Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Kidney Fibrosis Drugs Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Kidney Fibrosis Drugs Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Kidney Fibrosis Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Kidney Fibrosis Drugs Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Kidney Fibrosis Drugs Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Kidney Fibrosis Drugs Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Kidney Fibrosis Drugs Production Market Share (2018-2023)
Table 37. China Based Kidney Fibrosis Drugs Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Kidney Fibrosis Drugs Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Kidney Fibrosis Drugs Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Kidney Fibrosis Drugs Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Kidney Fibrosis Drugs Production Market Share (2018-2023)
Table 42. Rest of World Based Kidney Fibrosis Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Kidney Fibrosis Drugs Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Kidney Fibrosis Drugs Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Kidney Fibrosis Drugs Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Kidney Fibrosis Drugs Production Market Share (2018-2023)
Table 47. World Kidney Fibrosis Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Kidney Fibrosis Drugs Production by Type (2018-2023) & (K Units)
Table 49. World Kidney Fibrosis Drugs Production by Type (2024-2029) & (K Units)
Table 50. World Kidney Fibrosis Drugs Production Value by Type (2018-2023) & (USD Million)
Table 51. World Kidney Fibrosis Drugs Production Value by Type (2024-2029) & (USD Million)
Table 52. World Kidney Fibrosis Drugs Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Kidney Fibrosis Drugs Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Kidney Fibrosis Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Kidney Fibrosis Drugs Production by Application (2018-2023) & (K Units)
Table 56. World Kidney Fibrosis Drugs Production by Application (2024-2029) & (K Units)
Table 57. World Kidney Fibrosis Drugs Production Value by Application (2018-2023) & (USD Million)
Table 58. World Kidney Fibrosis Drugs Production Value by Application (2024-2029) & (USD Million)
Table 59. World Kidney Fibrosis Drugs Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Kidney Fibrosis Drugs Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Merck and Co Basic Information, Manufacturing Base and Competitors
Table 62. Merck and Co Major Business
Table 63. Merck and Co Kidney Fibrosis Drugs Product and Services
Table 64. Merck and Co Kidney Fibrosis Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Merck and Co Recent Developments/Updates
Table 66. Merck and Co Competitive Strengths & Weaknesses
Table 67. Galectin Therapeutics Basic Information, Manufacturing Base and Competitors
Table 68. Galectin Therapeutics Major Business
Table 69. Galectin Therapeutics Kidney Fibrosis Drugs Product and Services
Table 70. Galectin Therapeutics Kidney Fibrosis Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Galectin Therapeutics Recent Developments/Updates
Table 72. Galectin Therapeutics Competitive Strengths & Weaknesses
Table 73. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 74. Pfizer Inc Major Business
Table 75. Pfizer Inc Kidney Fibrosis Drugs Product and Services
Table 76. Pfizer Inc Kidney Fibrosis Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Pfizer Inc Recent Developments/Updates
Table 78. Pfizer Inc Competitive Strengths & Weaknesses
Table 79. InterMune Inc Basic Information, Manufacturing Base and Competitors
Table 80. InterMune Inc Major Business
Table 81. InterMune Inc Kidney Fibrosis Drugs Product and Services
Table 82. InterMune Inc Kidney Fibrosis Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. InterMune Inc Recent Developments/Updates
Table 84. InterMune Inc Competitive Strengths & Weaknesses
Table 85. La Jolla Pharmaceutical Company Basic Information, Manufacturing Base and Competitors
Table 86. La Jolla Pharmaceutical Company Major Business
Table 87. La Jolla Pharmaceutical Company Kidney Fibrosis Drugs Product and Services
Table 88. La Jolla Pharmaceutical Company Kidney Fibrosis Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. La Jolla Pharmaceutical Company Recent Developments/Updates
Table 90. La Jolla Pharmaceutical Company Competitive Strengths & Weaknesses
Table 91. BioLine Rx Basic Information, Manufacturing Base and Competitors
Table 92. BioLine Rx Major Business
Table 93. BioLine Rx Kidney Fibrosis Drugs Product and Services
Table 94. BioLine Rx Kidney Fibrosis Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. BioLine Rx Recent Developments/Updates
Table 96. BioLine Rx Competitive Strengths & Weaknesses
Table 97. F. Hoffman-La Roche Basic Information, Manufacturing Base and Competitors
Table 98. F. Hoffman-La Roche Major Business
Table 99. F. Hoffman-La Roche Kidney Fibrosis Drugs Product and Services
Table 100. F. Hoffman-La Roche Kidney Fibrosis Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. F. Hoffman-La Roche Recent Developments/Updates
Table 102. F. Hoffman-La Roche Competitive Strengths & Weaknesses
Table 103. ProMetic Life-Sciences Inc Basic Information, Manufacturing Base and Competitors
Table 104. ProMetic Life-Sciences Inc Major Business
Table 105. ProMetic Life-Sciences Inc Kidney Fibrosis Drugs Product and Services
Table 106. ProMetic Life-Sciences Inc Kidney Fibrosis Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. ProMetic Life-Sciences Inc Recent Developments/Updates
Table 108. Genzyme Corporation Basic Information, Manufacturing Base and Competitors
Table 109. Genzyme Corporation Major Business
Table 110. Genzyme Corporation Kidney Fibrosis Drugs Product and Services
Table 111. Genzyme Corporation Kidney Fibrosis Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 112. Global Key Players of Kidney Fibrosis Drugs Upstream (Raw Materials)
Table 113. Kidney Fibrosis Drugs Typical Customers
Table 114. Kidney Fibrosis Drugs Typical Distributors
LIST OF FIGURES
Figure 1. Kidney Fibrosis Drugs Picture
Figure 2. World Kidney Fibrosis Drugs Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Kidney Fibrosis Drugs Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Kidney Fibrosis Drugs Production (2018-2029) & (K Units)
Figure 5. World Kidney Fibrosis Drugs Average Price (2018-2029) & (US$/Unit)
Figure 6. World Kidney Fibrosis Drugs Production Value Market Share by Region (2018-2029)
Figure 7. World Kidney Fibrosis Drugs Production Market Share by Region (2018-2029)
Figure 8. North America Kidney Fibrosis Drugs Production (2018-2029) & (K Units)
Figure 9. Europe Kidney Fibrosis Drugs Production (2018-2029) & (K Units)
Figure 10. China Kidney Fibrosis Drugs Production (2018-2029) & (K Units)
Figure 11. Japan Kidney Fibrosis Drugs Production (2018-2029) & (K Units)
Figure 12. Kidney Fibrosis Drugs Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Kidney Fibrosis Drugs Consumption (2018-2029) & (K Units)
Figure 15. World Kidney Fibrosis Drugs Consumption Market Share by Region (2018-2029)
Figure 16. United States Kidney Fibrosis Drugs Consumption (2018-2029) & (K Units)
Figure 17. China Kidney Fibrosis Drugs Consumption (2018-2029) & (K Units)
Figure 18. Europe Kidney Fibrosis Drugs Consumption (2018-2029) & (K Units)
Figure 19. Japan Kidney Fibrosis Drugs Consumption (2018-2029) & (K Units)
Figure 20. South Korea Kidney Fibrosis Drugs Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Kidney Fibrosis Drugs Consumption (2018-2029) & (K Units)
Figure 22. India Kidney Fibrosis Drugs Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Kidney Fibrosis Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Kidney Fibrosis Drugs Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Kidney Fibrosis Drugs Markets in 2022
Figure 26. United States VS China: Kidney Fibrosis Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Kidney Fibrosis Drugs Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Kidney Fibrosis Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Kidney Fibrosis Drugs Production Market Share 2022
Figure 30. China Based Manufacturers Kidney Fibrosis Drugs Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Kidney Fibrosis Drugs Production Market Share 2022
Figure 32. World Kidney Fibrosis Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Kidney Fibrosis Drugs Production Value Market Share by Type in 2022
Figure 34. Angiotensin Converting Enzyme (ACE) Inhibitors
Figure 35. Pirfenidone
Figure 36. Renin Inhibitors
Figure 37. Angiotensin II Receptor Blockers (ARBs)
Figure 38. Vasopeptidase Inhibitors
Figure 39. World Kidney Fibrosis Drugs Production Market Share by Type (2018-2029)
Figure 40. World Kidney Fibrosis Drugs Production Value Market Share by Type (2018-2029)
Figure 41. World Kidney Fibrosis Drugs Average Price by Type (2018-2029) & (US$/Unit)
Figure 42. World Kidney Fibrosis Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 43. World Kidney Fibrosis Drugs Production Value Market Share by Application in 2022
Figure 44. Chronic Kidney Diseases
Figure 45. Kidney Cancer Treatment
Figure 46. Others
Figure 47. World Kidney Fibrosis Drugs Production Market Share by Application (2018-2029)
Figure 48. World Kidney Fibrosis Drugs Production Value Market Share by Application (2018-2029)
Figure 49. World Kidney Fibrosis Drugs Average Price by Application (2018-2029) & (US$/Unit)
Figure 50. Kidney Fibrosis Drugs Industry Chain
Figure 51. Kidney Fibrosis Drugs Procurement Model
Figure 52. Kidney Fibrosis Drugs Sales Model
Figure 53. Kidney Fibrosis Drugs Sales Channels, Direct Sales, and Distribution
Figure 54. Methodology
Figure 55. Research Process and Data Source
Figure 1. Kidney Fibrosis Drugs Picture
Figure 2. World Kidney Fibrosis Drugs Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Kidney Fibrosis Drugs Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Kidney Fibrosis Drugs Production (2018-2029) & (K Units)
Figure 5. World Kidney Fibrosis Drugs Average Price (2018-2029) & (US$/Unit)
Figure 6. World Kidney Fibrosis Drugs Production Value Market Share by Region (2018-2029)
Figure 7. World Kidney Fibrosis Drugs Production Market Share by Region (2018-2029)
Figure 8. North America Kidney Fibrosis Drugs Production (2018-2029) & (K Units)
Figure 9. Europe Kidney Fibrosis Drugs Production (2018-2029) & (K Units)
Figure 10. China Kidney Fibrosis Drugs Production (2018-2029) & (K Units)
Figure 11. Japan Kidney Fibrosis Drugs Production (2018-2029) & (K Units)
Figure 12. Kidney Fibrosis Drugs Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Kidney Fibrosis Drugs Consumption (2018-2029) & (K Units)
Figure 15. World Kidney Fibrosis Drugs Consumption Market Share by Region (2018-2029)
Figure 16. United States Kidney Fibrosis Drugs Consumption (2018-2029) & (K Units)
Figure 17. China Kidney Fibrosis Drugs Consumption (2018-2029) & (K Units)
Figure 18. Europe Kidney Fibrosis Drugs Consumption (2018-2029) & (K Units)
Figure 19. Japan Kidney Fibrosis Drugs Consumption (2018-2029) & (K Units)
Figure 20. South Korea Kidney Fibrosis Drugs Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Kidney Fibrosis Drugs Consumption (2018-2029) & (K Units)
Figure 22. India Kidney Fibrosis Drugs Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Kidney Fibrosis Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Kidney Fibrosis Drugs Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Kidney Fibrosis Drugs Markets in 2022
Figure 26. United States VS China: Kidney Fibrosis Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Kidney Fibrosis Drugs Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Kidney Fibrosis Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Kidney Fibrosis Drugs Production Market Share 2022
Figure 30. China Based Manufacturers Kidney Fibrosis Drugs Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Kidney Fibrosis Drugs Production Market Share 2022
Figure 32. World Kidney Fibrosis Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Kidney Fibrosis Drugs Production Value Market Share by Type in 2022
Figure 34. Angiotensin Converting Enzyme (ACE) Inhibitors
Figure 35. Pirfenidone
Figure 36. Renin Inhibitors
Figure 37. Angiotensin II Receptor Blockers (ARBs)
Figure 38. Vasopeptidase Inhibitors
Figure 39. World Kidney Fibrosis Drugs Production Market Share by Type (2018-2029)
Figure 40. World Kidney Fibrosis Drugs Production Value Market Share by Type (2018-2029)
Figure 41. World Kidney Fibrosis Drugs Average Price by Type (2018-2029) & (US$/Unit)
Figure 42. World Kidney Fibrosis Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 43. World Kidney Fibrosis Drugs Production Value Market Share by Application in 2022
Figure 44. Chronic Kidney Diseases
Figure 45. Kidney Cancer Treatment
Figure 46. Others
Figure 47. World Kidney Fibrosis Drugs Production Market Share by Application (2018-2029)
Figure 48. World Kidney Fibrosis Drugs Production Value Market Share by Application (2018-2029)
Figure 49. World Kidney Fibrosis Drugs Average Price by Application (2018-2029) & (US$/Unit)
Figure 50. Kidney Fibrosis Drugs Industry Chain
Figure 51. Kidney Fibrosis Drugs Procurement Model
Figure 52. Kidney Fibrosis Drugs Sales Model
Figure 53. Kidney Fibrosis Drugs Sales Channels, Direct Sales, and Distribution
Figure 54. Methodology
Figure 55. Research Process and Data Source
